Characterization of long non-coding RNA H19 in epithelial to mesenchymal transition: 長非編碼RNA H19在上皮間充質轉化中的功能探究
Colorectal cancer (CRC), with an estimated 1.2 million new cases annually, is the third leading cause of cancer incidence and death worldwide. Generally, the majority of CRC patients are diagnosed at the advanced stages with poor prognosis and unfavorable response to multiple therapeutic drugs. In s...
Other Authors: | |
---|---|
Format: | Others |
Language: | English Chinese |
Published: |
2014
|
Subjects: | |
Online Access: | http://repository.lib.cuhk.edu.hk/en/item/cuhk-1290666 |
id |
ndltd-cuhk.edu.hk-oai-cuhk-dr-cuhk_1290666 |
---|---|
record_format |
oai_dc |
collection |
NDLTD |
language |
English Chinese |
format |
Others
|
sources |
NDLTD |
topic |
Colon (Anatomy)--Cancer--Genetic aspects Rectum--Cancer--Genetic aspects Carcinogenesis--Molecular aspects Epithelial-Mesenchymal Transition--genetics Colorectal Neoplasms--genetics |
spellingShingle |
Colon (Anatomy)--Cancer--Genetic aspects Rectum--Cancer--Genetic aspects Carcinogenesis--Molecular aspects Epithelial-Mesenchymal Transition--genetics Colorectal Neoplasms--genetics Characterization of long non-coding RNA H19 in epithelial to mesenchymal transition: 長非編碼RNA H19在上皮間充質轉化中的功能探究 |
description |
Colorectal cancer (CRC), with an estimated 1.2 million new cases annually, is the third leading cause of cancer incidence and death worldwide. Generally, the majority of CRC patients are diagnosed at the advanced stages with poor prognosis and unfavorable response to multiple therapeutic drugs. In spite of increasing knowledge of the molecular mechanism for the tumorigenesis in CRC patients, the translation from basic science into clinical therapy has been limited for quite a long time. In order to develop novel treatment strategies against CRC, intensive and extensive attempts have been made in the past decades. === The epithelial to mesenchymal transition (EMT) is a multi-step process characterized by the loss of cell polarity, decreased cell-cell adhesion as well as enhanced migration and invasion capacity. It is well documented that EMT is essential for a variety of cellular biological events ranging from embryogenesis to tumor progression. The field of lncRNA is developing rapidly and currently it is one of the most intensively studied fields in the biomedical sciences. Emerging evidence indicates that the majority of human genome encodes thousands of non-protein-coding RNA transcripts, nevertheless, the function of long non-coding RNAs (lncRNAs) in orchestrating EMT progression remains elusive. Historically, the lncRNA H19 was the first identified imprinted non-coding RNA transcript in human, and the H19/IGF2 locus acted as an ideal paradigm for the investigation of genomic imprinting genes. In recent years, the expression profiling and functional characterization of the H19 gene in a variety of human diseases has been extensively studied. === In our studies, H19 was characterized as a novel regulator of EMT in colon cancer. We first observed significant mesenchymal characteristics in the methotrexate-resistant HT-29 cells. Interestingly, significant upregulation of H19 was observed in mesenchymal-like MTX resistant HT-29 cells. We subsequently demonstrated that after treatment of TGF-β1, one of the most widely used EMT inducers, H19 presented dramatic increase during the EMT progression. To further investigate the functional role of H19 in EMT, we generated the stable cell lines overexpressing H19 in colon cancer cells using retroviral infection. Stable overexpression of H19 significantly promoted EMT progression in two epithelial colon cancer cell lines HT-29 and HCT-116. However, overexpression of H19 did not affect cell proliferation as well as cell cycle progression. Further proteomics studies screened out that ectopic expression of H19 upregulated the protein level of Vimentin, a vital biomarker for mesenchymal cells. By using the bioinformatics study in combination with luciferase reporter assays, we demonstrated that H19 potentiated the expression of several core marker genes essential for mesenchymal cells by serving as a competing endogenous RNA(ceRNA), which builds up the missing link between the regulatory miRNA network and EMT progression. According to the results from xenograft tumor model and soft agar assay, stable expression of H19 reinforced the in vitro and in vivo tumor growth. Moreover, the investigation of clinical specimens verified that H19 RNA level was significantly increased in colon cancer tissues compared with corresponding adjacent normal tissues. Taken together, the above observations imply that the lncRNA H19, by acting as a competing endogenous RNA, is an important regulator which tightly modulated the expression of multiple important genes involved in EMT and it could probably serve as a novel therapeutic target against colon cancer. === 大腸癌每年有一百二十萬新增個案,是世界第三大癌症殺手。通常情況下,大部分大腸癌病人發現時已經處於晚期,該時期的癌症病人對多種臨床治療藥物已無法治愈。盡管關於大腸癌發病的分子生物學機制已經不斷完善,但如何從基礎研究轉化為臨床治療手段在很長一段時間內不可實現。為了進一步研究新的抗擊大腸癌治療手段,廣泛且深入的研究已經不斷開展。 === 上皮間充質轉化是一個多步驟的過程,該過程的典型特徵為失去細胞的極性,細胞間粘連減弱以及細胞爬行遷移能力的不斷加強。目前科學家已經知道上皮間充質轉化對於從胚胎發育到腫瘤發展都起著重要的作用。近年來,長非編碼RNA的研究不斷快速發展,已然成為醫學研究中最激烈的領域之一。眾多證據表明人體基因組編碼數以千計不編碼蛋白質的RNA轉錄體。然而,這些RNA轉錄體在上皮間充質轉化中的功能依然所知甚少。長非編碼RNA H19是人體內第一個被鑒別出來參與到基因印記的非編碼RNA。資料表明H19/IGF2位點是一個非常理想的研究基因印記的位點。近年來,H19在眾多癌症中的表達以及功能學研究已不斷湧現,同時也不斷取得令人鼓舞的研究成果。 === 在我們的研究中,H19被鑒定為大腸癌裏上皮間充質轉化過程中一個重要的參與者。通過研究甲氨蝶呤耐藥大腸癌HT-29細胞株,我們發現該HT-29耐藥細胞株有著顯著的間充質細胞特性。有趣的是,H19在該細胞株中有著顯著升高。我們隨後用經典的上皮間充質轉化誘導劑TGF-β1處理兩株大腸癌細胞,處理後H19亦有著顯著升高。為了進一步研究H19在上皮間充質轉化,通過使用逆轉錄病毒,我們建立H19的穩定表達細胞株。穩定表達H19顯著地促進了HT-29以及SW620大腸癌細胞株的上皮間充質轉化。然後,高水平表達(過表達)H19並不影響細胞的生長以及細胞周期的進程。進一步的蛋白質組學研究表明,過表達H19能促進間充質細胞一個重要標記基因Vimentin的表達。通過生物信息學以及熒光素酶報告基因實驗,我們證明了H19通過其競爭內源性RNA的作用,能夠促進間充質細胞所需的幾個重要基因的表達。該發現建立起了miRNA網絡以及上皮間充質轉化進程的交流網絡。通過異位移植以及軟瓊脂實驗,我們發現過表達H19能夠促進腫瘤細胞的生長。而在臨床大腸癌病人組織中,我們更發現H19在大腸癌病人組織中高表達。綜上所述,我們的結果證明H19這一長非編碼RNA,能夠通過其競爭內源性RNA的作用機制,從而調控上皮間充質轉化過程中的關鍵基因。同時H19亦有可能成為治療大腸癌的臨床新靶點。 === Liang, Weicheng. === Thesis (Ph.D.)--Chinese University of Hong Kong, 2014. === Includes bibliographical references (leaves 95-124). === Abstracts also in Chinese. === Title from PDF title page (viewed on 24, October, 2016). === Liang, Weicheng. |
author2 |
Liang, Weicheng (author.) |
author_facet |
Liang, Weicheng (author.) |
title |
Characterization of long non-coding RNA H19 in epithelial to mesenchymal transition: 長非編碼RNA H19在上皮間充質轉化中的功能探究 |
title_short |
Characterization of long non-coding RNA H19 in epithelial to mesenchymal transition: 長非編碼RNA H19在上皮間充質轉化中的功能探究 |
title_full |
Characterization of long non-coding RNA H19 in epithelial to mesenchymal transition: 長非編碼RNA H19在上皮間充質轉化中的功能探究 |
title_fullStr |
Characterization of long non-coding RNA H19 in epithelial to mesenchymal transition: 長非編碼RNA H19在上皮間充質轉化中的功能探究 |
title_full_unstemmed |
Characterization of long non-coding RNA H19 in epithelial to mesenchymal transition: 長非編碼RNA H19在上皮間充質轉化中的功能探究 |
title_sort |
characterization of long non-coding rna h19 in epithelial to mesenchymal transition: 長非編碼rna h19在上皮間充質轉化中的功能探究 |
publishDate |
2014 |
url |
http://repository.lib.cuhk.edu.hk/en/item/cuhk-1290666 |
_version_ |
1718978038202368000 |
spelling |
ndltd-cuhk.edu.hk-oai-cuhk-dr-cuhk_12906662019-02-19T03:46:57Z Characterization of long non-coding RNA H19 in epithelial to mesenchymal transition: 長非編碼RNA H19在上皮間充質轉化中的功能探究 長非編碼RNA H19在上皮間充質轉化中的功能探究 CUHK electronic theses & dissertations collection Characterization of long non-coding RNA H19 in epithelial to mesenchymal transition: Chang fei bian ma RNA H19 zai shang pi jian chong zhi zhuan hua zhong de gong neng tan jiu Chang fei bian ma RNA H19 zai shang pi jian chong zhi zhuan hua zhong de gong neng tan jiu Colon (Anatomy)--Cancer--Genetic aspects Rectum--Cancer--Genetic aspects Carcinogenesis--Molecular aspects Epithelial-Mesenchymal Transition--genetics Colorectal Neoplasms--genetics Colorectal cancer (CRC), with an estimated 1.2 million new cases annually, is the third leading cause of cancer incidence and death worldwide. Generally, the majority of CRC patients are diagnosed at the advanced stages with poor prognosis and unfavorable response to multiple therapeutic drugs. In spite of increasing knowledge of the molecular mechanism for the tumorigenesis in CRC patients, the translation from basic science into clinical therapy has been limited for quite a long time. In order to develop novel treatment strategies against CRC, intensive and extensive attempts have been made in the past decades. The epithelial to mesenchymal transition (EMT) is a multi-step process characterized by the loss of cell polarity, decreased cell-cell adhesion as well as enhanced migration and invasion capacity. It is well documented that EMT is essential for a variety of cellular biological events ranging from embryogenesis to tumor progression. The field of lncRNA is developing rapidly and currently it is one of the most intensively studied fields in the biomedical sciences. Emerging evidence indicates that the majority of human genome encodes thousands of non-protein-coding RNA transcripts, nevertheless, the function of long non-coding RNAs (lncRNAs) in orchestrating EMT progression remains elusive. Historically, the lncRNA H19 was the first identified imprinted non-coding RNA transcript in human, and the H19/IGF2 locus acted as an ideal paradigm for the investigation of genomic imprinting genes. In recent years, the expression profiling and functional characterization of the H19 gene in a variety of human diseases has been extensively studied. In our studies, H19 was characterized as a novel regulator of EMT in colon cancer. We first observed significant mesenchymal characteristics in the methotrexate-resistant HT-29 cells. Interestingly, significant upregulation of H19 was observed in mesenchymal-like MTX resistant HT-29 cells. We subsequently demonstrated that after treatment of TGF-β1, one of the most widely used EMT inducers, H19 presented dramatic increase during the EMT progression. To further investigate the functional role of H19 in EMT, we generated the stable cell lines overexpressing H19 in colon cancer cells using retroviral infection. Stable overexpression of H19 significantly promoted EMT progression in two epithelial colon cancer cell lines HT-29 and HCT-116. However, overexpression of H19 did not affect cell proliferation as well as cell cycle progression. Further proteomics studies screened out that ectopic expression of H19 upregulated the protein level of Vimentin, a vital biomarker for mesenchymal cells. By using the bioinformatics study in combination with luciferase reporter assays, we demonstrated that H19 potentiated the expression of several core marker genes essential for mesenchymal cells by serving as a competing endogenous RNA(ceRNA), which builds up the missing link between the regulatory miRNA network and EMT progression. According to the results from xenograft tumor model and soft agar assay, stable expression of H19 reinforced the in vitro and in vivo tumor growth. Moreover, the investigation of clinical specimens verified that H19 RNA level was significantly increased in colon cancer tissues compared with corresponding adjacent normal tissues. Taken together, the above observations imply that the lncRNA H19, by acting as a competing endogenous RNA, is an important regulator which tightly modulated the expression of multiple important genes involved in EMT and it could probably serve as a novel therapeutic target against colon cancer. 大腸癌每年有一百二十萬新增個案,是世界第三大癌症殺手。通常情況下,大部分大腸癌病人發現時已經處於晚期,該時期的癌症病人對多種臨床治療藥物已無法治愈。盡管關於大腸癌發病的分子生物學機制已經不斷完善,但如何從基礎研究轉化為臨床治療手段在很長一段時間內不可實現。為了進一步研究新的抗擊大腸癌治療手段,廣泛且深入的研究已經不斷開展。 上皮間充質轉化是一個多步驟的過程,該過程的典型特徵為失去細胞的極性,細胞間粘連減弱以及細胞爬行遷移能力的不斷加強。目前科學家已經知道上皮間充質轉化對於從胚胎發育到腫瘤發展都起著重要的作用。近年來,長非編碼RNA的研究不斷快速發展,已然成為醫學研究中最激烈的領域之一。眾多證據表明人體基因組編碼數以千計不編碼蛋白質的RNA轉錄體。然而,這些RNA轉錄體在上皮間充質轉化中的功能依然所知甚少。長非編碼RNA H19是人體內第一個被鑒別出來參與到基因印記的非編碼RNA。資料表明H19/IGF2位點是一個非常理想的研究基因印記的位點。近年來,H19在眾多癌症中的表達以及功能學研究已不斷湧現,同時也不斷取得令人鼓舞的研究成果。 在我們的研究中,H19被鑒定為大腸癌裏上皮間充質轉化過程中一個重要的參與者。通過研究甲氨蝶呤耐藥大腸癌HT-29細胞株,我們發現該HT-29耐藥細胞株有著顯著的間充質細胞特性。有趣的是,H19在該細胞株中有著顯著升高。我們隨後用經典的上皮間充質轉化誘導劑TGF-β1處理兩株大腸癌細胞,處理後H19亦有著顯著升高。為了進一步研究H19在上皮間充質轉化,通過使用逆轉錄病毒,我們建立H19的穩定表達細胞株。穩定表達H19顯著地促進了HT-29以及SW620大腸癌細胞株的上皮間充質轉化。然後,高水平表達(過表達)H19並不影響細胞的生長以及細胞周期的進程。進一步的蛋白質組學研究表明,過表達H19能促進間充質細胞一個重要標記基因Vimentin的表達。通過生物信息學以及熒光素酶報告基因實驗,我們證明了H19通過其競爭內源性RNA的作用,能夠促進間充質細胞所需的幾個重要基因的表達。該發現建立起了miRNA網絡以及上皮間充質轉化進程的交流網絡。通過異位移植以及軟瓊脂實驗,我們發現過表達H19能夠促進腫瘤細胞的生長。而在臨床大腸癌病人組織中,我們更發現H19在大腸癌病人組織中高表達。綜上所述,我們的結果證明H19這一長非編碼RNA,能夠通過其競爭內源性RNA的作用機制,從而調控上皮間充質轉化過程中的關鍵基因。同時H19亦有可能成為治療大腸癌的臨床新靶點。 Liang, Weicheng. Thesis (Ph.D.)--Chinese University of Hong Kong, 2014. Includes bibliographical references (leaves 95-124). Abstracts also in Chinese. Title from PDF title page (viewed on 24, October, 2016). Liang, Weicheng. Liang, Weicheng (author.) Waye, Mary Miu Yee (thesis advisor.) Chinese University of Hong Kong Graduate School. Division of Biomedical Sciences. (degree granting institution.) 2014 Text bibliography text electronic resource] electronic resource remote 1 online resource (xiii, 149 leaves) : illustrations (some color) computer online resource cuhk:1290666 local: etd920160188 local: AAI3691929 local: 991018541719703407 eng chi Use of this resource is governed by the terms and conditions of the Creative Commons "Attribution-NonCommercial-NoDerivatives 4.0 International" License (http://creativecommons.org/licenses/by-nc-nd/4.0/) http://repository.lib.cuhk.edu.hk/en/islandora/object/cuhk%3A1290666/datastream/TN/view/Characterization%20of%20long%20non-coding%20RNA%20H19%20in%20epithelial%20to%20mesenchymal%20transition%20%3A%20%E9%95%B7%E9%9D%9E%E7%B7%A8%E7%A2%BCRNA%20H19%E5%9C%A8%E4%B8%8A%E7%9A%AE%E9%96%93%E5%85%85%E8%B3%AA%E8%BD%89%E5%8C%96%E4%B8%AD%E7%9A%84%E5%8A%9F%E8%83%BD%E6%8E%A2%E7%A9%B6.jpghttp://repository.lib.cuhk.edu.hk/en/item/cuhk-1290666 |